(Q34111234)

31 July 2017

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa (English)

1 reference

31 July 2017

0 references

0 references

1 reference

Modou L Jobarteh

2

0 references

Matthew Cotten

object named as

Matthew Cotten

11

0 references

Thushan I de Silva

object named as

Thushan de Silva

5

0 references

Sarah Rowland-Jones

9

object named as

Sarah Rowland-Jones

1 reference

31 July 2017

8

Hilton Whittle

1 reference

31 July 2017

10

Assan Jaye

1 reference

31 July 2017

3

Ramu Sarge-Njie

1 reference

31 July 2017

12

Maimuna Mendy

1 reference

31 July 2017

7

Ingrid Peterson

1 reference

31 July 2017

Balint Stewart

1

1 reference

31 July 2017

Abraham Alabi

4

1 reference

31 July 2017

Kevin Peterson

6

1 reference

31 July 2017

23 December 2011

1 reference

31 July 2017

1 reference

31 July 2017

4

1 reference

31 July 2017

561

1 reference

Creative Commons Attribution 2.0 Generic

31 July 2017

start time

1 December 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1756-0500-4-561

0 references

cites work

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

HIV-2: the forgotten AIDS virus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Current treatment of HIV/hepatitis B virus coinfection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-561

Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Hepatitis B virus infection in two Gambian villages

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292846

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22195774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Management of chronic hepatitis B and C in HIV-coinfected patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22195774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22195774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1756-0500-4-561

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference